Details of the Drug

General Information of Drug (ID: DM7O6TV)

• Drug Name: NY-ESO-1 T-cell receptor therapy

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]

• Cross-matching ID: TTD ID: D0AO8L

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)